-
1
-
-
84897895162
-
Effects of glucagon-like peptide 1 on appetite and body weight: Focus on the CNS
-
van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol 2014;221:T1-T16
-
(2014)
J Endocrinol
, vol.221
, pp. T1-T16
-
-
Van Bloemendaal, L.1
Ten Kulve, J.S.2
La Fleur, S.E.3
Ijzerman, R.G.4
Diamant, M.5
-
2
-
-
84856000294
-
GLP-1, the gut-brain, and brain-periphery axes
-
Cabou C, Burcelin R. GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud 2011;8:418-431
-
(2011)
Rev Diabet Stud
, vol.8
, pp. 418-431
-
-
Cabou, C.1
Burcelin, R.2
-
3
-
-
13644268431
-
The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
-
Alvarez E, Martínez MD, Roncero I, et al. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 2005;92:798-806
-
(2005)
J Neurochem
, vol.92
, pp. 798-806
-
-
Alvarez, E.1
Martínez, M.D.2
Roncero, I.3
-
4
-
-
79952310049
-
Secretion of glucagonlike peptide-1 (GLP-1) in type 2 diabetes: What is up, what is down?
-
Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagonlike peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011;54:10-18
-
(2011)
Diabetologia
, vol.54
, pp. 10-18
-
-
Nauck, M.A.1
Vardarli, I.2
Deacon, C.F.3
Holst, J.J.4
Meier, J.J.5
-
5
-
-
84878808238
-
Pharmacology, physiology, and mechanisms of incretin hormone action
-
Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013;17:819-837
-
(2013)
Cell Metab
, vol.17
, pp. 819-837
-
-
Campbell, J.E.1
Drucker, D.J.2
-
6
-
-
0036198285
-
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
-
Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 2002;18:7-14
-
(2002)
J Mol Neurosci
, vol.18
, pp. 7-14
-
-
Kastin, A.J.1
Akerstrom, V.2
Pan, W.3
-
7
-
-
48449093468
-
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
-
Muscelli E, Mari A, Casolaro A, et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008;57:1340-1348
-
(2008)
Diabetes
, vol.57
, pp. 1340-1348
-
-
Muscelli, E.1
Mari, A.2
Casolaro, A.3
-
8
-
-
84871564295
-
Direct effect of GLP-1 infusion on endogenous glucose production in humans
-
Seghieri M, Rebelos E, Gastaldelli A, et al. Direct effect of GLP-1 infusion on endogenous glucose production in humans. Diabetologia 2013;56:156-161
-
(2013)
Diabetologia
, vol.56
, pp. 156-161
-
-
Seghieri, M.1
Rebelos, E.2
Gastaldelli, A.3
-
9
-
-
84858713174
-
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
-
Hunter K, Hölscher C. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 2012;13:33
-
(2012)
BMC Neurosci
, vol.13
, pp. 33
-
-
Hunter, K.1
Hölscher, C.2
-
10
-
-
0037349072
-
Entry of exendin-4 into brain is rapid but may be limited at high doses
-
Kastin AJ, Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 2003;27:313-318
-
(2003)
Int J Obes Relat Metab Disord
, vol.27
, pp. 313-318
-
-
Kastin, A.J.1
Akerstrom, V.2
-
11
-
-
84885977398
-
Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity
-
Schlögl H, Kabisch S, Horstmann A, et al. Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care 2013;36:1933-1940
-
(2013)
Diabetes Care
, vol.36
, pp. 1933-1940
-
-
Schlögl, H.1
Kabisch, S.2
Horstmann, A.3
-
12
-
-
40749107089
-
Glucagon-like peptide-1 inhibits bloodbrain glucose transfer in humans
-
Lerche S, Brock B, Rungby J, et al. Glucagon-like peptide-1 inhibits bloodbrain glucose transfer in humans. Diabetes 2008;57:325-331
-
(2008)
Diabetes
, vol.57
, pp. 325-331
-
-
Lerche, S.1
Brock, B.2
Rungby, J.3
-
13
-
-
84870624506
-
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia
-
Gejl M, Egefjord L, Lerche S, et al. Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia. J Cereb Blood Flow Metab 2012;32:2146-2152
-
(2012)
J Cereb Blood Flow Metab
, vol.32
, pp. 2146-2152
-
-
Gejl, M.1
Egefjord, L.2
Lerche, S.3
-
14
-
-
84902208322
-
Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect
-
Sisley S, Gutierrez-Aguilar R, Scott M, D'Alessio DA, Sandoval DA, Seeley RJ. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect. J Clin Invest 2014;124:2456-2463
-
(2014)
J Clin Invest
, vol.124
, pp. 2456-2463
-
-
Sisley, S.1
Gutierrez-Aguilar, R.2
Scott, M.3
D'Alessio, D.A.4
Sandoval, D.A.5
Seeley, R.J.6
-
15
-
-
0032856158
-
Altered hypothalamic function in response to glucose ingestion in obese humans
-
Matsuda M, Liu Y, Mahankali S, et al. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 1999;48:1801-1806
-
(1999)
Diabetes
, vol.48
, pp. 1801-1806
-
-
Matsuda, M.1
Liu, Y.2
Mahankali, S.3
-
16
-
-
10244241840
-
Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: Evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake
-
Navarro M, Rodriquez de Fonseca F, Alvarez E, et al. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J Neurochem 1996;67:1982-1991
-
(1996)
J Neurochem
, vol.67
, pp. 1982-1991
-
-
Navarro, M.1
Rodriquez De Fonseca, F.2
Alvarez, E.3
-
17
-
-
0347360368
-
Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose
-
Yang XJ, Kow LM, Pfaff DW, Mobbs CV. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004;53:67-73
-
(2004)
Diabetes
, vol.53
, pp. 67-73
-
-
Yang, X.J.1
Kow, L.M.2
Pfaff, D.W.3
Mobbs, C.V.4
-
18
-
-
84920367212
-
Glucokinase activity in the arcuate nucleus regulates glucose intake
-
Hussain S, Richardson E, Ma Y, et al. Glucokinase activity in the arcuate nucleus regulates glucose intake. J Clin Invest 2015;125:337-349
-
(2015)
J Clin Invest
, vol.125
, pp. 337-349
-
-
Hussain, S.1
Richardson, E.2
Ma, Y.3
-
20
-
-
0032883250
-
No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans
-
Hasselbalch SG, Knudsen GM, Videbaek C, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999;48:1915-1921
-
(1999)
Diabetes
, vol.48
, pp. 1915-1921
-
-
Hasselbalch, S.G.1
Knudsen, G.M.2
Videbaek, C.3
-
21
-
-
0036895563
-
The role of insulin in human brain glucose metabolism: An 18fluoro-deoxyglucose positron emission tomography study
-
Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002;51:3384-3390
-
(2002)
Diabetes
, vol.51
, pp. 3384-3390
-
-
Bingham, E.M.1
Hopkins, D.2
Smith, D.3
|